Effects of Ankaferd Blood Stopper and Celox on the Tissue Factor Activities of Warfarin-Treated Rats

被引:18
作者
Aktop, Sertac [1 ]
Emekli-Alturfan, Ebru [2 ]
Ozer, Cuneyt [3 ]
Gonul, Onur [1 ]
Garip, Hasan [1 ]
Yarat, Aysen [2 ]
Goker, Kamil [1 ]
机构
[1] Marmara Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Istanbul, Turkey
[2] Marmara Univ, Div Biochem, Dept Basic Med Sci, Fac Dent, Istanbul, Turkey
[3] Kocaeli Univ, Dept Expt Anim Searching Unit, Kocaeli, Turkey
关键词
anticoagulants; chitosan; tissue factor; hemostasis; Ankaferd Blood Stopper; Celox; DENTAL EXTRACTIONS; THROMBIN; HEMOSTASIS; EFFICACY; CHITOSAN; TRIAL; TIME;
D O I
10.1177/1076029613490254
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to evaluate the effect of these new generation hemostatic agents on early-stage soft tissue healing of warfarin-treated rats by measuring the tissue factor (TF) activities. Rats in the warfarin group were treated intraperitonally with 0.1 mg/kg warfarin, and rats in the control group were treated with 1 mL/kg saline. All rats had 3 incisions on dorsal dermal tissue applied Celox, Ankaferd Blood Stopper (ABS), or no hemostatic agent. Six rats from each group were killed on day 4, and the other 6 were killed on day 8. Prothrombin time (PT) and TF activities were evaluated, respectively. Both the hemostatic agents positively affected the hemostasis. Warfarin treatment increased the PT levels as expected. Celox-treated dermal tissues had higher TF activity when compared to ABS-treated ones. The ABS affected the early-stage healing positively in clinical aspect, whereas Celox was more effective on hemostasis by means of increasing TF activities.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 40 条
[21]   The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model [J].
Kosar, Ali ;
Cipil, Handan S. ;
Kaya, Arif ;
Uz, Burak ;
Haznedaroglu, Ibrahim C. ;
Goker, Hakan ;
Ozdemir, Oktay ;
Ercetin, Sevil ;
Kirazli, Serafettin ;
Firat, Huseyin Cahit .
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (03) :185-190
[22]   An alternative hemostatic dressing: Comparison of CELOX, HemCon, and QuikClot [J].
Kozen, Buddy G. ;
Kircher, Sara J. ;
Henao, Jose ;
Godinez, Fermin S. ;
Johnson, Andrew S. .
ACADEMIC EMERGENCY MEDICINE, 2008, 15 (01) :74-81
[23]   Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability [J].
Kurt, Mevlut ;
Oztas, Erkin ;
Kuran, Sedef ;
Onal, Ibrahim K. ;
Kekilli, Murat ;
Haznedaroglu, Ibrahim C. .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2009, 27 (05) :631.e1-631.e2
[24]   Role of tissue factor in hemostasis, thrombosis, and vascular development [J].
Mackman, N .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (06) :1015-1022
[25]   CHITOSAN - A NEW HEMOSTATIC [J].
MALETTE, WG ;
QUIGLEY, HJ ;
GAINES, RD ;
JOHNSON, ND ;
RAINER, WG .
ANNALS OF THORACIC SURGERY, 1983, 36 (01) :55-58
[26]   Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa [J].
Nicholson, AC ;
Nachman, RL ;
Altieri, DC ;
Summers, BD ;
Ruf, W ;
Edgington, TS ;
Hajjar, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28407-28413
[27]   Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa [J].
Ollivier, V ;
Chabbat, J ;
Herbert, JM ;
Hakim, J ;
de Prost, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (05) :1374-1381
[28]   Tissue factor, the blood, and the arterial wall [J].
Rauch, U ;
Nemerson, Y .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (04) :139-143
[29]   The use of local agents: Surgicel and Surgifoam [J].
Sabel, M ;
Stummer, W .
EUROPEAN SPINE JOURNAL, 2004, 13 (Suppl 1) :S97-S101
[30]   Bleeding after dental extractions in patients taking warfarin [J].
Salam, S. ;
Yusuf, H. ;
Milosevic, A. .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2007, 45 (06) :463-466